Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Hypertrophic Cardiomyopathy Clinical Trials

100 recruiting trials for Hypertrophic Cardiomyopathy. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
100
Total Trials
100
Recruiting Now
5
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT05662293

Characterization of Arrhythmia-induced Cardiomyopathy

The goal of the this observational study is to gather clinically available data on patients presenting with a suspicion for arrhythmia-induced cardiomyopathy (AiCM) at the...

Sponsor: University Hospital, Basel, SwitzerlandEnrolling: 27001 location
RECRUITINGNCT05521451

Clinical Cohort Study - TRUST

The "Long-term Outcome and Predictors for Recurrence after Medical and Interventional Treatment of Arrhythmias at the University Heart Center Hamburg" (TRUST) study is an...

Sponsor: Universitätsklinikum Hamburg-EppendorfEnrolling: 50001 location
RECRUITINGNCT06095466

Cirrhotic Cardiomyopathy Based on Point-of-care Echocardiography, Biomarkers and Histology

Cirrhotic cardiomyopathy is associated with increased risk of complications like hepatorenal syndrome, refractory ascites, impaired response to stressors including sepsis,...

Sponsor: Post Graduate Institute of Medical Education and Research, ChandigarhEnrolling: 1501 location
RECRUITINGNCT06371937

iPSC Biobank of Biomarkers Diversity in Cardiovascular Disease

The Investigators will create a clinical database and a Biobank of stem cells derived from the blood of participants with cardiovascular disease. The Investigators will recruit...

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sEnrolling: 2001 location
RECRUITINGNCT07344480

Retrospective Natural History Study of RASopathy-associated Cardiomyopathy (RAS-CM)

RASopathy-associated hypertrophic cardiomyopathy (RAS-CM) is a disease with high morbidity and high mortality if presenting during infancy. Targeted therapies have shown...

Sponsor: Deutsches Herzzentrum MuenchenEnrolling: 1001 location
RECRUITINGNCT06001073

Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics

The etiology and specific pathogenesis of many cardiovascular diseases such as coronary atherosclerosis, cardiomyopathy, atrial fibrillation, and stroke are still unclear....

Sponsor: First Affiliated Hospital Xi'an Jiaotong UniversityEnrolling: 250001 location
RECRUITINGNCT05467163

Conduction System Pacing Versus Biventricular Pacing After Atrioventricular Node Ablation

Atrioventricular node ablation (AVNA) with biventricular (BiV) pacemaker implantation is a feasible treatment option in patients with symptomatic refractory atrial fibrillation...

Sponsor: University Medical Centre LjubljanaEnrolling: 8210 locations
RECRUITINGNCT06400524

Assessment of Cardiac Function, Microvascular Function and Cardiac Perfusion in Different Disease Stages of...

Hypertrophic cardiomyopathy (HCM) is a genetic disorder characterized by asymmetric hypertrophy of the heart in absence of loading conditions like hypertension. The genetic...

Sponsor: Amsterdam UMC, location VUmcEnrolling: 1001 location
RECRUITINGNCT06566209

FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis

The purpose of this pilot study is to evaluate Fluorodeoxyglucose - Positron Emission Tomography (FDG-PET) as an imaging modality to diagnose and risk stratify subclinical,...

Sponsor: Mayo ClinicEnrolling: 301 location
RECRUITINGPhase 1NCT07137338

A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated...

This is a Phase 1, open-label, dose-escalation trial to characterize the safety, tolerability, and preliminary efficacy of RP-A701 following a single IV administration in...

Sponsor: Rocket Pharmaceuticals Inc.Enrolling: 83 locations
RECRUITINGNCT04558723

Cardiac Magnetic Resonance Guidance of Implantable Cardioverter Defibrillator Implantation in Non-ischemic Dilated...

Patients with diagnostic CMR images for assessment of LGE/fibrosis and evidence/presence of non-ischaemic myocardial fibrosis/scar will be randomized to the following treatment...

Sponsor: Prof. Dr. med. Ingo EitelEnrolling: 7601 location
RECRUITINGNCT06040242

Arrhythmogenic Activity During Exercise in ARVC Patients

Current guidelines advocate that ARVC patients, typically young and active individuals with a significant history of competitive endurance sports, cease endurance training in...

Sponsor: Swiss Federal Institute of TechnologyEnrolling: 1201 location
RECRUITINGNCT06889662

GEAM Study Aims At Assessing the Role of Genetic Testing in Patients with Arrhythmic Myocarditis.

This study aims to answer multiple unsolved questions in the field of arrhythmic myocarditis. * Improving the diagnostic work-up. While endomyocardial biopsy (EMB) and cardiac...

Sponsor: Scientific Institute San RaffaeleEnrolling: 2621 location
RECRUITINGNCT05818605

Exercise Intolerance in Non-obstructive Hypertrophic Cardiomyopathy

The EXCITE-HCM study is a randomized, controlled, blinded clinical trial designed to evaluate the effect of moderate intensity exercise training versus usual physicial activity on...

Sponsor: University of California, San FranciscoEnrolling: 701 location
RECRUITINGNCT07224178

Left Atrial Strain and Cryptogenic Stroke

Cryptogenic stroke is a type of stroke in which the cause of the blood clot cannot be identified, leaving many patients without a clear treatment plan and at high risk for another...

Sponsor: University of PittsburghEnrolling: 9001 location
RECRUITINGNCT06795152

Rare Glycogen Storage Diseases Natural History Study

The purpose of this study is to collect and study key medical data about several ultra-rare GSDs (Glycogen Storage Diseases) including, but not limited to, GSD types 0a, 0b, VII,...

Sponsor: Duke UniversityEnrolling: 2001 location
RECRUITINGNCT06146660

A Study to Assess the Safety of Mavacamten in Korean Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy

The purpose of this observational post-marketing surveillance study is to assess the real-world safety of mavacamten for the treatment of symptomatic obstructive hypertrophic...

Sponsor: Bristol-Myers SquibbEnrolling: 6002 locations
RECRUITINGNCT05081115

Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging

With stress echo (SE) 2020 study, a new standard of practice in stress imaging was developed and disseminated: the ABCDE protocol for functional testing within and beyond CAD....

Sponsor: Fatebenefratelli HospitalEnrolling: 100001 location
RECRUITINGNCT02435940

Inherited Retinal Degenerative Disease Registry

The My Retina Tracker® Registry is sponsored by the Foundation Fighting Blindness and is for people affected by one of the rare inherited retinal degenerative diseases studied by...

Sponsor: Foundation Fighting BlindnessEnrolling: 200001 location
RECRUITINGPhase 4NCT04935021

Clinical Study of ATTR-CM

In this study, patients with ATTR-CM or gene carriers were selected to study the diagnosis and treatment, and long-term follow-up was conducted.

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang UniversityEnrolling: 1001 location
RECRUITINGNCT06311708

Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9)...

This is a multicenter, non-interventional study to observe the natural progression of the disease and to study the prevalence of pre-existing antibodies to AAV9 used for gene...

Sponsor: Tenaya TherapeuticsEnrolling: 20020 locations
RECRUITINGPhase 3NCT04853758

Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy With Reduced Ejection Fraction: ANSWER-HF.

Chagas disease is considered by the World Health Organization (WHO) as one of the most neglected tropical diseases in the world, having relevance in many Latin America countries....

Sponsor: University of Sao Paulo General HospitalEnrolling: 2001 location
RECRUITINGEarly Phase 1NCT06433050

Sodium Glucose Co-transporter (SGLT) Inhibitors in Nonobstructive Hypertrophic Cardiomyopathy

The goal of this clinical trial is to learn if sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, works to treat symptomatic, nonobstructive hypertrophic cardiomyopathy (noHCM) in...

Sponsor: University of PennsylvaniaEnrolling: 261 location
RECRUITINGPhase 2NCT05511246

Venous Ethanol for Ventricular Tachycardia

Comparative effectiveness randomized clinical trial, comparing endocardial radiofrequency ablation alone vs radiofrequency ablation combined with venous ethanol in patients with...

Sponsor: The Methodist Hospital Research InstituteEnrolling: 1561 location
RECRUITINGNCT05329285

CABG or PCI in Patients With Ischemic Cardiomyopathy

The STICH-SWEDEHEART trial will compare PCI vs CABG for revascularization of patients with HF and LV systolic dysfunction (LV ejection fraction (LVEF) \<40%) and multi-vessel...

Sponsor: Vastra Gotaland RegionEnrolling: 4701 location
RECRUITINGPhase 2 / Phase 3NCT07210723

A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated...

The Sponsor is studying an investigational medication called danicamtiv to determine if it can help people with genetic and familial dilated cardiomyopathy (DCM). Investigational...

Sponsor: Kardigan, Inc.Enrolling: 33220 locations
RECRUITINGNCT04225520

AMEND-CRT: Mechanical Dyssynchrony as Selection Criterion for CRT

Previous experience with cardiac resynchronization therapy (CRT) candidates suggests that selection of these patients can be improved. Current clinical guideline approaches are...

Sponsor: Universitaire Ziekenhuizen KU LeuvenEnrolling: 70020 locations
RECRUITINGNCT07336394

Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance...

What is this study about? This research is focused on improving the care for people with rare heart muscle diseases, known as rare cardiomyopathies. These are uncommon conditions...

Sponsor: Chinese Academy of Medical Sciences, Fuwai HospitalEnrolling: 10001 location
RECRUITINGNCT06124196

Wearable Technology to Evaluate Hyperglycemia and HRV in DMD

Duchenne muscular dystrophy (DMD) is an X-linked disorder that causes muscle wasting, cardiopulmonary failure, and premature death. Heart failure is a leading cause of death in...

Sponsor: Vanderbilt University Medical CenterEnrolling: 801 location
RECRUITINGNCT06101108

Early Diagnosis of Age-Linked CArdiac TransThyRetin Amyloidosis by Selective Screening in Spinal Stenosis Surgery

The goal of this observational study is to keep track of the cardiological follow-up of patients who have undergone back surgery because of symptomatic narrowing of the spinal...

Sponsor: Philippe DebonnaireEnrolling: 4001 location
RECRUITINGNCT06836011

A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence,...

The objective of this prospective registry study is to comprehensively characterize the prevalence, (semi-) quantitative parameters, and associated clinical outcomes of mitral...

Sponsor: Medical University of ViennaEnrolling: 6008 locations
RECRUITINGNCT03586518

Validating Novel, Non-contrast Cardiac MRI Imaging in Haemodialysis Patients

There are currently no good ways of measuring levels of scarring in the hearts of patients with advanced kidney disease and patients on dialysis, although recent research has...

Sponsor: University of LeicesterEnrolling: 91 location
RECRUITINGNCT06377033

Using the EHR to Advance Genomic Medicine Across a Diverse Health System

Given the expansion of indications for genetic testing and our understanding of conditions for which the results change medical management, it is imperative to consider novel ways...

Sponsor: University of PennsylvaniaEnrolling: 10001 location
RECRUITINGPhase 2NCT06660732

Rilonacept in Subjects With Cardiac Sarcoidosis

The primary objective of this study is to evaluate the effect of rilonacept, added to standard therapy and compared with standard therapy alone, on improvement in myocardial...

Sponsor: Mayo ClinicEnrolling: 602 locations
RECRUITINGNCT05554835

Global Registry and Natural History Study for Mitochondrial Disorders

The main goal of the project is provision of a global registry for mitochondrial disorders to harmonize previous national registries, enable world-wide participation and...

Sponsor: LMU KlinikumEnrolling: 600018 locations
RECRUITINGPhase 4NCT06401343

Use of SGLT2i in noHCM With HFpEF

This study aims to evaluate the impact of Sodium-dependent glucose transporters 2 inhibitor Empagliflozin on the exercise capacity,symptoms of heart failure, cardiac function,...

Sponsor: China National Center for Cardiovascular DiseasesEnrolling: 941 location
RECRUITINGPhase 1 / Phase 2NCT06634108

Genistein in trAnSthyretin recePtor Amyloid caRdiomyopathy

This Phase 1b/2a study aims to investigate the safety and efficacy of genistein in patients with Transthyretin (TTR) Amyloidosis. The focus is on its impact on inflammatory and...

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sEnrolling: 201 location
RECRUITINGNCT06010199

Risk Stratification Value of Biomarkers in Patients With Myocarditis

The aim of this study is to collect clinical data and biological specimens from patients with myocarditis and construct a predictive model for the prognosis of myocarditis.

Sponsor: First Affiliated Hospital Xi'an Jiaotong UniversityEnrolling: 10001 location
RECRUITINGNCT06922851

Protein A Immunoadsorption in Dilated Cardiomyopathy (RPIA-DCM)

This study is a multicenter, dual-arm and randomized controlled clinical trial. Sixty patients with dilated cardiomyopathy and positive β1-adrenergic receptor autoantibodies were...

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyEnrolling: 601 location
RECRUITINGNCT07250529

Left Bundle Branch Pacing vs Right Ventricular Pacing on AHRE Burden in Patients With Preserved LVEF

This prospective, randomized controlled trial aims to evaluate the effect of left bundle branch pacing (LBBP) compared with conventional right ventricular (RV) pacing on the...

Sponsor: University Hospital of PatrasEnrolling: 2441 location
RECRUITINGNCT05519735

Lymphatic Organs and Myocardium After Myocardial Infarction

The adaptive immune response plays an important role in myocardial healing and remodeling after acute myocardial infarction in patients. Therefore, the involved lymphocytes...

Sponsor: Wuerzburg University HospitalEnrolling: 572 locations
RECRUITINGNCT05750147

The SMARTER Cardiomyopathy Study

Cardiomyopathies are diseases of the heart muscle. Known genetic factors may account for some cardiomyopathy cases but there is still much to understand about the genetic and...

Sponsor: Imperial College LondonEnrolling: 10002 locations
RECRUITINGNCT07286643

Echocardiography-guided Cirrhosis and Liver Failure-Intensive Care Protocol Sepsis

* Point-of-care echocardiography is used to guide septic shock resuscitation in patients with severe sepsis in the intensive care unit (ICU), but without systematic evidence for...

Sponsor: Post Graduate Institute of Medical Education and Research, ChandigarhEnrolling: 1401 location
RECRUITINGNCT06573723

Institutional Registry of Rare Diseases

The goal of this observational study is to create a single macro registry system with data collection on common clinical features, grouping the different rare diseases (RD)....

Sponsor: Hospital Italiano de Buenos AiresEnrolling: 3801 location
RECRUITINGNCT07054073

HCMR Re-Imaging Study

This study aims to learn what might predict heart problems (like sudden death from a fast heart rhythm or heart failure) in people with a genetic condition called hypertrophic...

Sponsor: Christopher KramerEnrolling: 3148 locations
RECRUITINGNCT05888662

Endo-epicardial vs Endocardial-only Catheter Ablation of Ventricular Tachycardia in Patients With Ischemic...

Radiofrequency ablation of ventricular tachycardias (VTs) is the gold standard treatment of refractory VTs in patients with ischaemic heart disease. In this setting, ablation is...

Sponsor: Rennes University HospitalEnrolling: 15012 locations
RECRUITINGNCT05507879

TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer

This study examines TRPC6 in predicting and preventing chemotherapy related cardiac toxicity and heart failure in patients with breast cancer. Cardiac toxicity, changes in heart...

Sponsor: Mayo ClinicEnrolling: 2002 locations
RECRUITINGPhase 2NCT07367724

Ademetionine in Obstructive Hypertrophic Cardiomyopathy

This study is a multicenter, double-blind, randomized controlled Phase 2 trial designed to evaluate the safety and efficacy of Ademetionine in patients with obstructive...

Sponsor: China National Center for Cardiovascular DiseasesEnrolling: 443 locations
RECRUITINGNCT01999140

Implantable Cardioverter Defibrillator (ICD Registry)

The ICD Registry™ is a nationwide quality program that helps participating hospitals measure and improve care for patients receiving implantable cardioverter defibrillators (ICDs)...

Sponsor: American College of CardiologyEnrolling: 17501 location
RECRUITINGNCT03479580

Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry

Long-term prognostic value of macrovascular and microvascular coronary artery stenoses in each type of cardiomyopathy.

Sponsor: University Hospital, GrenobleEnrolling: 16001 location

Showing 50 of 100 trials.Search all Hypertrophic Cardiomyopathy trials